Skip to main content
Erschienen in: Clinical Rheumatology 10/2011

01.10.2011 | Case Based Review

A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine

verfasst von: Rachel L. Gross, Jason Brucker, Asena Bahce-Altuntas, Maria A. Abadi, Jules Lipoff, David Kotlyar, Peter Barland, Chaim Putterman

Erschienen in: Clinical Rheumatology | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

In order to describe the clinical and serologic features of a cutaneous vasculitis due to cocaine contaminated with the adulterant levamisole, we report four new cases of this syndrome along with 12 previously reported cases identified through a PubMed Literature search (1964 to March 2011). Of the 16 patients described, the average age was 43, with a female predominance (81% of patients). Over half of patients had involvement of the earlobes, and the rash frequently affected the extremities in a “retiform” pattern. Leukopenia or neutropenia was reported in 56% of patients. Ninety-three percent were anti-neutrophil cytoplasmic antibody positive, and 63% tested positive for anti-phospholipid antibodies. The predominant pattern seen on histopathological examination of the skin was small vessel vasculitis and/or a thrombotic vasculopathy. Treatment in these patients varied widely, with several patients showing improvement or resolution of the rash without specific therapy following cessation of illicit drug use. This new cutaneous vasculitis syndrome can be recognized by its characteristic rash and skin pathology, together with leukopenia and autoantibody production. Certain clinical features can be attributed to the adulterant levamisole, though cocaine as well may play a role in its pathogenesis.
Literatur
1.
Zurück zum Zitat Bhinder S, Majithia V (2007) Cocaine use and its rheumatic manifestations. Clin Rheumatol 26:1192–1194PubMedCrossRef Bhinder S, Majithia V (2007) Cocaine use and its rheumatic manifestations. Clin Rheumatol 26:1192–1194PubMedCrossRef
2.
Zurück zum Zitat Bradford M, Rosenberg B, Moreno J, Dumyati G (2010) Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 152(11):758–759PubMed Bradford M, Rosenberg B, Moreno J, Dumyati G (2010) Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 152(11):758–759PubMed
3.
Zurück zum Zitat Buchanan JA, Vogel JA, Eberhardt AM (2011) Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 7(1):83–84PubMedCrossRef Buchanan JA, Vogel JA, Eberhardt AM (2011) Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 7(1):83–84PubMedCrossRef
4.
Zurück zum Zitat Walsh NMG, Green PJ, Burlingame RW, Pasternak S, Hanly JG (2010) Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 37(12):1212–1219PubMedCrossRef Walsh NMG, Green PJ, Burlingame RW, Pasternak S, Hanly JG (2010) Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 37(12):1212–1219PubMedCrossRef
5.
Zurück zum Zitat Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP (2010) Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit? J Am Acad Dermatol 63(3):530–535PubMedCrossRef Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP (2010) Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit? J Am Acad Dermatol 63(3):530–535PubMedCrossRef
6.
Zurück zum Zitat Farhat EK, Moorhead TT, Chaffing ML, Douglass MC (2010) Levamisole-induced cutaneous necrosis mimicking coagulopathy. Arch Dermatol 146(11):1320–1321PubMedCrossRef Farhat EK, Moorhead TT, Chaffing ML, Douglass MC (2010) Levamisole-induced cutaneous necrosis mimicking coagulopathy. Arch Dermatol 146(11):1320–1321PubMedCrossRef
7.
Zurück zum Zitat Click J (2011) Levamisole-induced retiform purpura. J Drug Dermatol 10(2):217 Click J (2011) Levamisole-induced retiform purpura. J Drug Dermatol 10(2):217
8.
Zurück zum Zitat Geller L, Whang TB, Mercer SE, Phelps R (2011) Retiform purpura: a new stigmata of illicit drug use? Dermatol Online J 17(2):7PubMed Geller L, Whang TB, Mercer SE, Phelps R (2011) Retiform purpura: a new stigmata of illicit drug use? Dermatol Online J 17(2):7PubMed
11.
Zurück zum Zitat Amery WK, Bruynseels JP (1992) Levamisole, the story and the lessons. Int J Immunopharmacol 14(3):481–486PubMedCrossRef Amery WK, Bruynseels JP (1992) Levamisole, the story and the lessons. Int J Immunopharmacol 14(3):481–486PubMedCrossRef
12.
Zurück zum Zitat Runge LA, Pinals RS, Lourie SH, Tomar RH (1977) Treatment of rheumatoid arthritis with levamisole. A controlled trial. Arthritis Rheum 20(8):1445–1448PubMedCrossRef Runge LA, Pinals RS, Lourie SH, Tomar RH (1977) Treatment of rheumatoid arthritis with levamisole. A controlled trial. Arthritis Rheum 20(8):1445–1448PubMedCrossRef
13.
Zurück zum Zitat Christensen KD (1979) Treatment of seronegative spondylarthritis with levamisole: a double-blind placebo-controlled study. Int J Immunopharmacol 1(2):147–150PubMedCrossRef Christensen KD (1979) Treatment of seronegative spondylarthritis with levamisole: a double-blind placebo-controlled study. Int J Immunopharmacol 1(2):147–150PubMedCrossRef
14.
Zurück zum Zitat Tanphaichitr P, Tanphaichitr D, Sureeratanan J, Chatasingh S (1980) Treatment of nephrotic syndrome with levamisole. J Pediatr 96:490–493PubMedCrossRef Tanphaichitr P, Tanphaichitr D, Sureeratanan J, Chatasingh S (1980) Treatment of nephrotic syndrome with levamisole. J Pediatr 96:490–493PubMedCrossRef
15.
Zurück zum Zitat Wauwe JV, Janssen PAJ (1991) On the biochemical mode of action of levamisole: an update. Int J Immunopharmacol 13(1):3–9PubMedCrossRef Wauwe JV, Janssen PAJ (1991) On the biochemical mode of action of levamisole: an update. Int J Immunopharmacol 13(1):3–9PubMedCrossRef
16.
Zurück zum Zitat Chen LY, Lin YL, Chiang BL (2008) Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells. Clin Exp Immunol 151(1):174–181PubMedCrossRef Chen LY, Lin YL, Chiang BL (2008) Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells. Clin Exp Immunol 151(1):174–181PubMedCrossRef
17.
Zurück zum Zitat Chang A, Osterloh J, Thomas J (2010) Levamisole: a dangerous new adulterant. Clin Pharmacol Ther 88(3):408–411PubMedCrossRef Chang A, Osterloh J, Thomas J (2010) Levamisole: a dangerous new adulterant. Clin Pharmacol Ther 88(3):408–411PubMedCrossRef
19.
Zurück zum Zitat Valentino AMM, Fuentecilla K (2005) Levamisole: an analytical profile. Microgram J 3(3-4):134–137 Valentino AMM, Fuentecilla K (2005) Levamisole: an analytical profile. Microgram J 3(3-4):134–137
20.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2009). Agranulocytosis associated with cocaine use—four states, March 2008–November 2009. MMWR 58(49):1381–1385 Centers for Disease Control and Prevention (CDC) (2009). Agranulocytosis associated with cocaine use—four states, March 2008–November 2009. MMWR 58(49):1381–1385
21.
Zurück zum Zitat Menni S, Gianotti R, Ghio L, Edefonti A (1997) Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 14(6):477–479PubMedCrossRef Menni S, Gianotti R, Ghio L, Edefonti A (1997) Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 14(6):477–479PubMedCrossRef
22.
Zurück zum Zitat Rongioletti F, Ghio L, Ginervi F et al (1999) Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 140:948–951PubMedCrossRef Rongioletti F, Ghio L, Ginervi F et al (1999) Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 140:948–951PubMedCrossRef
23.
Zurück zum Zitat Powell J, Grech H, Holder J (2002) A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol 27(1):32–33PubMedCrossRef Powell J, Grech H, Holder J (2002) A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol 27(1):32–33PubMedCrossRef
24.
Zurück zum Zitat Scheinberg MA, Gomes Bezerra JB, Almeida FA, Silveira LA (1978) Cutaneous necrotizing vasculitis induced by levamisole. Br Med J 1(6110):408PubMedCrossRef Scheinberg MA, Gomes Bezerra JB, Almeida FA, Silveira LA (1978) Cutaneous necrotizing vasculitis induced by levamisole. Br Med J 1(6110):408PubMedCrossRef
25.
Zurück zum Zitat Brewer JD, Meves A, Bostwick M, Hamacher KL, Pittelkow MR (2008) Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol 59(3):483–487PubMedCrossRef Brewer JD, Meves A, Bostwick M, Hamacher KL, Pittelkow MR (2008) Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol 59(3):483–487PubMedCrossRef
26.
Zurück zum Zitat Friedman DR, Wolfsthal SD (2005) Cocaine-induced pseudovasculitis. Mayo Clin Proc 80(5):671–673PubMedCrossRef Friedman DR, Wolfsthal SD (2005) Cocaine-induced pseudovasculitis. Mayo Clin Proc 80(5):671–673PubMedCrossRef
27.
28.
Zurück zum Zitat Williams GT, Johnson SA, Dieppe PA, Huskisson EC (1978) Neutropenia during treatment of rheumatoid arthritis with levamisole. Ann Rheum Dis 37(4):366–369PubMedCrossRef Williams GT, Johnson SA, Dieppe PA, Huskisson EC (1978) Neutropenia during treatment of rheumatoid arthritis with levamisole. Ann Rheum Dis 37(4):366–369PubMedCrossRef
29.
Zurück zum Zitat Teerenhov L, Heinonen E, Gröhn P, Klefström P, Mehtonen M, Tiilikainen A (1978) High frequency of agranulocytosis in breast-cancer patients treated with levamisole. Lancet 2(8081):151–152CrossRef Teerenhov L, Heinonen E, Gröhn P, Klefström P, Mehtonen M, Tiilikainen A (1978) High frequency of agranulocytosis in breast-cancer patients treated with levamisole. Lancet 2(8081):151–152CrossRef
30.
Zurück zum Zitat Rosenthal M, Breysse Y, Dixon AS et al (1977) Levamisole and agranulocytosis. Lancet 1(8017):904–905PubMedCrossRef Rosenthal M, Breysse Y, Dixon AS et al (1977) Levamisole and agranulocytosis. Lancet 1(8017):904–905PubMedCrossRef
31.
Zurück zum Zitat Buchanan JA, Oyer RJ, Patel NR et al (2010) A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 6:160–164PubMedCrossRef Buchanan JA, Oyer RJ, Patel NR et al (2010) A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 6:160–164PubMedCrossRef
32.
Zurück zum Zitat Wiens MO, Son WK, Ross C, Hayden M, Carelton B (2010) Cocaine adulterant linked to neutropenia. CMJA 182(1):57–59CrossRef Wiens MO, Son WK, Ross C, Hayden M, Carelton B (2010) Cocaine adulterant linked to neutropenia. CMJA 182(1):57–59CrossRef
33.
Zurück zum Zitat Zhu MY, LeGatt DF, Turner AR (2009) Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Int Med 150(4):287–289PubMed Zhu MY, LeGatt DF, Turner AR (2009) Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Int Med 150(4):287–289PubMed
34.
Zurück zum Zitat Knowles L, Buxton JA, Skuridina N et al (2009) Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduction J 6:30CrossRef Knowles L, Buxton JA, Skuridina N et al (2009) Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduction J 6:30CrossRef
35.
Zurück zum Zitat Hodinka I, Géher P, Merétey K, Gyódi EK, Petrányi GG, Bozsóky S (1981) Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol 65(4):460–464PubMedCrossRef Hodinka I, Géher P, Merétey K, Gyódi EK, Petrányi GG, Bozsóky S (1981) Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol 65(4):460–464PubMedCrossRef
36.
Zurück zum Zitat Schmidt KL, Mueller-Eckhardt C (1977) Agranulocytosis, levamisole, and HLA-B27. Lancet 2(8028):85PubMedCrossRef Schmidt KL, Mueller-Eckhardt C (1977) Agranulocytosis, levamisole, and HLA-B27. Lancet 2(8028):85PubMedCrossRef
37.
Zurück zum Zitat Czuchlewski DR, Brackney M, Ewers C et al (2010) Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 133:466–472PubMedCrossRef Czuchlewski DR, Brackney M, Ewers C et al (2010) Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 133:466–472PubMedCrossRef
38.
Zurück zum Zitat Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WH, Seitz MA, Messer G, Wollenberg A (2008) PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol 88(6):594–596PubMed Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WH, Seitz MA, Messer G, Wollenberg A (2008) PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol 88(6):594–596PubMed
39.
Zurück zum Zitat Fritsma GA, Leikin JB, Maturen AJ, Froelich CJ, Hryhorczuk DO (1991) Detection of anticardiolipin antibody in patients with cocaine abuse. J Emerg Med 9(Suppl 1):37–43PubMedCrossRef Fritsma GA, Leikin JB, Maturen AJ, Froelich CJ, Hryhorczuk DO (1991) Detection of anticardiolipin antibody in patients with cocaine abuse. J Emerg Med 9(Suppl 1):37–43PubMedCrossRef
40.
Zurück zum Zitat Wiesner O, Russel KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, Specks U (2004) Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 50(9):2954–2965PubMedCrossRef Wiesner O, Russel KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, Specks U (2004) Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 50(9):2954–2965PubMedCrossRef
41.
Zurück zum Zitat Kouassi E, Caille G, Lery L, Larivière L, Vézina M (1986) Novel assay and pharmacokinetics of levamisole and p-hydroxylevamsiole in human plasma and urine. Biopharm Drug Dispos 7(1):71–89PubMedCrossRef Kouassi E, Caille G, Lery L, Larivière L, Vézina M (1986) Novel assay and pharmacokinetics of levamisole and p-hydroxylevamsiole in human plasma and urine. Biopharm Drug Dispos 7(1):71–89PubMedCrossRef
Metadaten
Titel
A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine
verfasst von
Rachel L. Gross
Jason Brucker
Asena Bahce-Altuntas
Maria A. Abadi
Jules Lipoff
David Kotlyar
Peter Barland
Chaim Putterman
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 10/2011
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1805-3

Weitere Artikel der Ausgabe 10/2011

Clinical Rheumatology 10/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.